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Abstract
Calcium, protein and vitamin D are 
the main nutrients relevant to bone 
health. This short article discusses the 
importance of vitamin D and its relation to 
calcium homeostasis. The various causes, 
clinical manifestations and treatment are 
outlined.
Vitamin D deficiency and effects 
on bone
The main nutrients relevant for bone 
health are calcium, protein and vitamin 
D. Calcium intake has been shown to be 
weakly related to bone mineral density and 
in two recent meta-analysis1 was found to 
be associated with a modest reduction of 
fracture risk. The ideal calcium allowance 
is unclear. It is reasonable to intervene with 
calcium supplementation when dietary 
calcium intake cannot be increased above 
800mg/day. The problem is complicated 
by the observation that 
Vitamin D is important in calcium 
homeostasis and may also need 
supplementation. 
Vitamin D deficiency which occurs with 
serum 25-hydroxyvitamin D levels below 
<25nmol/l results in osteomalacia in 
adults and rickets in children. Commonly 
patients are asymptomatic or may present 
with non-specific bone pain, fractures, 
hypocalcaemia and myopathy. 
Vitamin D insufficiency is defined by 
consensus as a serum 25-hydroxyvitamin 
D level of <75nmol/l.  When vitamin D 
levels fall below 75nmol/l,  parathormone 
(PTH) secreted by the parathyroid glands 
starts to rise. The clinical consequences 
are debatable but it may be associated 
with osteomalacia, bone aches and poor 
bone mineralisation.
Pathophysiology
Vitamin D is formed from the effect 
of UVB-sunlight on 7-dehydrocholesterol 
in the skin2,3. There are 2 forms of 
vitamin D: vitamin D2 (ergocalciferol) 
and vitamin D3 (cholecalciferol). Both 
forms are hydroxylated to the 25-OH 
form in the liver. Further hydroxylation 
of the 25-OH vitamin D in the kidney 
results in production of the active form 
1,25-dihydroxyvitamin D. Vitamin D 
production in the skin declines with 
advancing age, such that elderly people 
rely more on vitamin D dietary intake. 
Some studies1 have suggested that 
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vitamin D3 may be more active than 
vitamin D2 but more recently it was 
demonstrated that they are equally 
effective. 
Vitamin D functions
• Enhances calcium and phosphate 
absorption from the gut;
• Stimulates osteoblast production;
• Decreases PTH synthesis.
Causes of osteomalacia and rickets
• Dietary deficiency;
• Reduced sun exposure;
• Pseudovitamin D deficiency rickets 
(autosomal recessive, presents in 1st 
year of life);
• Hereditary vitamin D resistance rickets 
(autosomal recessive, presents in 
infancy);
• Hypophosphataemic vitamin D 
resistant rickets (X linked, presents in 
childhood);
• Autosomal dominant 
hypophosphatemic rickets (autosomal 
dominant, presents in infancy).
People at risk of vitamin D deficiency
• Elderly particularly those in institutions;
• Excessive use of sunscreen;
• Dark skinned people living at high 
altitudes;
• Ethnic/religious reasons which may 
demand coverage of all the skin;
• Malabsorption conditions eg: coeliac 
disease, short bowel syndrome, cystic 
fibrosis;
• Chronic liver disease;
• Drugs eg: prolonged anticonvulsant 
use, cholestyramine, aluminum 
containing antacids.
Vitamin D insufficiency is not exclusive 
to the elderly. Studies have shown that up 
to two thirds of healthy adults have vitamin 
D insufficiency and this tends to be worse 
after winter and improves after summer4,5.  
Treatment of vitamin D insufficiency 
may decrease the risk of hip and 
nonvertebral fractures. In the elderly 
vitamin D supplementation has been 
associated with a reduction in falls and 
enhanced muscle strength6. A meta-
analysis1 demonstrated that vitamin D 
supplementation resulted in a reduction 
in falls of about 22% in ambulatory 
institutionalized elderly subjects, 
compared with controls.  A Cochrane 
Review1 including 50 randomized, 
controlled trials involving close to 
100,000 individuals, has found vitamin D3 
supplementation to be associated with 
significant reduction in mortality while other 
forms of vitamin D (vitamin D2, calcitriol, and 
alpha-calcidiol) did not.
Lab investigation
• Serum calcium is usually normal, serum 
phosphate maybe normal or low, serum 
Alkaline Phosphatase may be normal or 
raised.
• The level of 25-OH vitamin D is usually < 
25nmol/l.
• PTH is usually > 5pmol/l although this 
does not need to be measured in all 
patients.
• Other tests such as liver and renal 
function, anti-TTG, folate and thyroid 
function may be needed to rule out other 
associated conditions or conditions which 
may mimic symptomatology.
Imaging
Pseudofractures (small radiolucent 
lines through bone cortices) may be seen 
characteristically in the femoral neck, pelvis 
and ribs.
In children growth plate abnormalities 
such as blurring of the growth plate, widening 
of the epiphyses and splaying of the long 
bone metaphyses can be observed.
Treatment
Maintenance
The recommended daily intake of vitamin 
D is controversial. The daily maintenance dose 
of vitamin D varies by age, but most children 
and adults generally require 400-2000 IU of 
vitamin D daily (1 mcg = 40 International Units 
(IU)).  Caution is needed when recommending 
vitamin D supplements as some brands which 
are not classified and registered as medicines 
(and hence do not have to comply with the 
stringent regulations and quality, medicines 
have to comply with) may not contain the 
amount of vitamin D stated on the packaging.
Prevention and treatment of osteoporosis
• 800-1,000 IU orally daily with calcium.
Treatment of Vitamin D deficiency
Cholecalciferol orally
• 50,000 units weekly for 6 weeks
• 20,000 units weekly for 12 weeks
Ergocalciferol im
• 300,000 units stat repeat after 6 weeks if 
still low.   
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